2008 - Enhanced efficacy of therapy of anti-CD20 antibody with Locked Nucleic Acid antisense oligonucleotide targeting Bcl-2 in human Burkitt's lymphoma xenografts

A. Molhart Hoga, M. Hillairet de Boisferonb, F. Bichatb, H. Frydenlund Hansena, J. Worma and J. Bo Hansena 

aOncodesign, bSantaris Pharma


By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.